Paz-Manrique, R., Ter, L.I., Alnadhari, I., Qayyum, S., Abu Hussein, N., Vieira Carneiro, B., Sakuma de Oliveira, C., Osman Elhag, B.E., Martines da Costa, M., Santos Bittencourt Silva, R., Montenegro Carrera, R.J., Antunes Kasa, M., Toribio Mejia, A.A., Silva de Paula Rocha, R., Faris, M.E., Barragan Berlanga, A.J., Furtado Campos, L., Elamin, H.H., González Mc.Cawley, F., Szylewicz, S., Hijazi Vega, S., Espinoza Briones, A., Bartié Rossi, G. and Camargo, C.P. 2020. Trimodal treatment for localized high risk prostate cancer: A design of a phase II, multi-center, open-label, randomized, parallel-group study to compare the effectiveness and safety of radical prostatectomy, external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT) versus EBRT and ADT for patients with localized high risk prostate cancer. Principles and Practice of Clinical Research. 6, 1 (May 2020), 3–8.